In a time of unprecedented public fear and distrust of institutions, life science companies must be more careful than ever in cultivating KOL relationships that can lend credibility to their products in the minds of the medical community. As regulations grow more strict, and demand for niche products and personalized treatment rises, KOLs are set to play an even more important role in each stage of the drug life cycle.

DGE’s 2nd KOL Engagement Forum is the only conference for life science professionals that focuses specifically on building and getting the most out of these partnerships. Don’t miss out on this unique learning and networking opportunity!